RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 561.00
+11.00 (2.00%)
Sep 4, 2025, 9:43 AM JST
RaQualia Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -375 | -357 | -294 | 851 | 880 | -527 | Upgrade |
Depreciation & Amortization | 479 | 401 | 175 | 147 | 141 | 124 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 1 | Upgrade |
Loss (Gain) From Sale of Investments | - | -3 | - | 35 | -16 | -1 | Upgrade |
Other Operating Activities | -133 | -100 | -128 | -203 | -81 | -85 | Upgrade |
Change in Accounts Receivable | 62 | -85 | - | 603 | -674 | 216 | Upgrade |
Change in Inventory | 2 | 3 | -139 | 2 | -4 | -1 | Upgrade |
Change in Accounts Payable | -81 | -98 | -134 | 111 | 136 | -16 | Upgrade |
Change in Other Net Operating Assets | 113 | 419 | -198 | -66 | -16 | - | Upgrade |
Operating Cash Flow | 67 | 180 | -718 | 1,480 | 366 | -289 | Upgrade |
Operating Cash Flow Growth | - | - | - | 304.37% | - | - | Upgrade |
Capital Expenditures | -112 | -96 | -205 | -31 | -92 | -149 | Upgrade |
Cash Acquisitions | - | -3,879 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -15 | -19 | -17 | - | -13 | -6 | Upgrade |
Investment in Securities | -100 | 158 | 90 | -15 | -174 | 380 | Upgrade |
Other Investing Activities | 179 | 171 | -3 | -1 | - | - | Upgrade |
Investing Cash Flow | -48 | -3,665 | -135 | -47 | -279 | 225 | Upgrade |
Short-Term Debt Issued | - | 400 | - | - | 10 | - | Upgrade |
Long-Term Debt Issued | - | 3,357 | 50 | 13 | - | - | Upgrade |
Total Debt Issued | - | 3,757 | 50 | 13 | 10 | - | Upgrade |
Short-Term Debt Repaid | - | -400 | - | - | -10 | - | Upgrade |
Long-Term Debt Repaid | - | -387 | -11 | -2 | - | - | Upgrade |
Total Debt Repaid | -512 | -787 | -11 | -2 | -10 | - | Upgrade |
Net Debt Issued (Repaid) | -512 | 2,970 | 39 | 11 | - | - | Upgrade |
Issuance of Common Stock | 1,098 | 80 | 805 | 4 | 1 | - | Upgrade |
Other Financing Activities | -126 | -68 | -51 | -44 | -17 | -6 | Upgrade |
Financing Cash Flow | 460 | 2,982 | 793 | -29 | -16 | -6 | Upgrade |
Foreign Exchange Rate Adjustments | -171 | -20 | 45 | 35 | 109 | -68 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 1 | 1 | -1 | -1 | - | Upgrade |
Net Cash Flow | 308 | -522 | -14 | 1,438 | 179 | -138 | Upgrade |
Free Cash Flow | -45 | 84 | -923 | 1,449 | 274 | -438 | Upgrade |
Free Cash Flow Growth | - | - | - | 428.83% | - | - | Upgrade |
Free Cash Flow Margin | -1.39% | 2.70% | -48.55% | 49.66% | 9.87% | -39.57% | Upgrade |
Free Cash Flow Per Share | -2.02 | 3.88 | -42.72 | 69.06 | 13.06 | -20.91 | Upgrade |
Cash Interest Paid | 57 | 42 | 6 | 6 | 1 | - | Upgrade |
Cash Income Tax Paid | 132 | 100 | 109 | 183 | 76 | 92 | Upgrade |
Levered Free Cash Flow | 56.75 | 415.63 | -694 | 1,172 | 64.88 | -203.75 | Upgrade |
Unlevered Free Cash Flow | 91.75 | 441.88 | -689.63 | 1,176 | 65.5 | -203.75 | Upgrade |
Change in Working Capital | 96 | 239 | -471 | 650 | -558 | 199 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.